| 利奈唑胺治疗院内MRSA肺炎的临床评价 |
| |
| 引用本文： | 毕鸿雁,杨宏军,田风. 利奈唑胺治疗院内MRSA肺炎的临床评价[J]. 西南科技大学学报(哲学社会科学版), 2009, 7(6): 38-39 |
| |
| 作者姓名： | 毕鸿雁 杨宏军 田风 |
| |
| 作者单位： | 昆明医学院第一附属医院干疗科,650031 |
| |
| 摘 要： | 目的 评价利奈唑胺治疗院内MRSA肺炎的临床疗效和安全性。方法 回顾分析13例MRSA感染的住院患者接受利奈唑胺治疗临床资料。结果 临床治愈13例，不良反应发生率7.7%。结论 应用利奈唑胺治疗院内MRSA肺炎能取得显著的临床效果及满意的细菌清除率，可作为院内MRSA肺炎的有效用药。
|
| 关 键 词： | 利奈唑胺 MRSA肺炎 院内 |
Clinical evaluation of linezolid for MRSA-related HAP |
| |
| BI Hongyan,YANG Hongjun,TIAN Feng. Clinical evaluation of linezolid for MRSA-related HAP[J]. Journal of Southwest University of Science and Technology, 2009, 7(6): 38-39 |
| |
| Authors: | BI Hongyan YANG Hongjun TIAN Feng |
| |
| Affiliation: | .(The department of Geratology,The first affiliated hospital of Kunming Medical College,Yunnan Province,650032 China.) |
| |
| Abstract: | Objective To evaluate therapeutic effect and drug safety of Linezolid in MRSA-related Hospital-associated Pneumonia（HAP） therapy. Methods Retrospective analysis the clinical of 13 patients,suffered form MRSA-related HAP,who treated with Linezolid. Results All patients get cured at clinical therapy criterion,and medicine adverse-reaction rate is 7.7%. Conclusion Linezolid could provide conspicuous effectiveness and satisfactory bacterium clearance rate in treatment of MRSA-related HAP,which would become the effective medicine for this disease. |
| |
| Keywords: | Linezolid，MRSA-related，Hospital-associated Pneumonia（HAP） |
| 本文献已被 维普 万方数据 等数据库收录！ |
|
